Showing results (591-600 of 750) with videos related to
Sort By:
Pageof 75
Journal of the American College of Cardiology|February 12, 2013
Does the instantaneous wave-free ratio approximate the fractional flow reserve?Nils P Johnson, Richard L Kirkeeide, Kaleab N Asrress, et al.JACC. Cardiovascular Interventions|November 21, 2009
Evaluation of the effect of a concurrent chronic total occlusion on long-term mortality and left ventricular function in patients after primary percutaneous coronary interventionBimmer E P M Claessen, René J van der Schaaf, Niels J Verouden, et al.Plos One|June 1, 2026
Impact of pre-segmented regions on CT-based evaluation of the Peritoneal Cancer Index: A reader studyLotte J S Fleurkens-Ewals, Marion W Tops-Welten, Anna F van Herwijnen, et al.Circulation. Cardiovascular Interventions|May 1, 2014
Physiological basis and long-term clinical outcome of discordance between fractional flow reserve and coronary flow velocity reserve in coronary stenoses of intermediate severityTim P van de Hoef, Martijn A van Lavieren, Peter Damman, et al.Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|April 25, 2018
Implantation techniques (predilatation, sizing, and post-dilatation) and the incidence of scaffold thrombosis and revascularisation in lesions treated with an everolimus-eluting bioresorbable vascular scaffold: insights from the AIDA trialRuben Yannick G Tijssen, Robin P Kraak, Joelle Elias, et al.Critical Care Medicine|May 24, 2011
The Impella 2.5 and 5.0 devices for ST-elevation myocardial infarction patients presenting with severe and profound cardiogenic shock: the Academic Medical Center intensive care unit experienceAnnemarie E Engström, Ricardo Cocchieri, Antoine H Driessen, et al.European Heart Journal|December 15, 2010
Intracoronary infusion of mononuclear cells from bone marrow or peripheral blood compared with standard therapy in patients after acute myocardial infarction treated by primary percutaneous coronary intervention: results of the randomized controlled HEBE trialAlexander Hirsch, Robin Nijveldt, Pieter A van der Vleuten, et al.Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 20, 2017
First-in-man randomised comparison of the BuMA Supreme biodegradable polymer sirolimus-eluting stent versus a durable polymer zotarolimus-eluting coronary stent: the PIONEER trialClemens von Birgelen, Taku Asano, Giovanni Amoroso, et al.Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|April 24, 2014
Increased hyperaemic coronary microvascular resistance adds to the presence of myocardial ischaemiaFroukje Nolte, Tim P van de Hoef, Martijn Meuwissen, et al.Frontiers in Cardiovascular Medicine|March 30, 2023
Meta-analysis and systematic review of coronary vasospasm in ANOCA patients: Prevalence, clinical features and prognosisJanneke Woudstra, Caitlin E M Vink, Diantha J M Schipaanboord, et al.Pageof 75